Referenc
Roberts DJ, Spickett RWJ, Moragues J, et al. Ebastine, a new nonsedating antihistamine. In: Proceedings of the Xth International Congress of Pharmacology; 1987: Sydney: 1006.
Moragues J, Roberts DJ. Ebastine. Drugs Fut 1990; 15: 674–9.
Torrent J, Barbanoj MF, Izquierdo I, et al. Ebastine pharmacokinetics and antihistamine effect in man [abstract]. NER Allergy Proc 1988; 9: 474.
Vincent J, Liminana R, Meredith PA, et al. The pharmacokinetics, antihistamine and concentration-effect relationship of ebastine in healthy subjects. Br J Clin Pharmacol 1988; 26: 497–502.
Wiseman LR, Faulds D. Ebastine: a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders. Drugs 1996; 51 (2): 260–77.
Rolf LN. Important drug warning. Marion Merrell Dow Inc. 6 Aug, 1990.
Monahan BP, Ferguson CL, Killeavy ES, et al. Torsades de pointes occurring in association with terfenadine use. JAMA 1990; 264: 2788–90.
Simons FER. H1-Receptor antagonists: comparative tolerability and safety. Drug Saf 1994; 10: 350–80.
Author information
Authors and Affiliations
Additional information
The data in this Short Communication have been presented in full in Annals of Allergy, Asthma and Immunology 1996; 76: 507–12. This article is published with the permission of the American College of Allergy Asthma and Immunology.
Rights and permissions
About this article
Cite this article
Cohen, B., Gehanno, P. Comparison of the Efficacy of Ebastine 10mg and 20mg Once Daily with that of Cetirizine 10mg Once Daily in Adults with Seasonal Allergic Rhinitis. Drugs 52 (Suppl 1), 26–29 (1996). https://doi.org/10.2165/00003495-199600521-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199600521-00007